Literature DB >> 19707189

Purification of recombinant high molecular weight two-partner secretion proteins from Escherichia coli.

James M Fleckenstein1, Koushik Roy.   

Abstract

This protocol describes the purification of a recombinant high molecular weight (HMW) two-partner secretion exoprotein (generically referred to as TpsA proteins) from Escherichia coli using methods developed recently to obtain highly purified flagellin-free recombinant EtpA (rEtpA) glycoprotein. The protocol addresses problems frequently encountered with the expression of these HMW proteins, namely plasmid instability and protein degradation, as well as a recently recognized issue of flagellin contamination. Briefly, the TpsA protein of interest is expressed with its outer membrane transporter (TpsB) protein in a flagellin-minus recombinant E. coli background. Culture supernatants are collected, concentrated through high molecular weight cutoff filters, followed by purification by size exclusion column chromatography. Details are included for the expression of HMW TpsA glycoproteins as polyhistidine-tagged molecules, which can be further purified by metal affinity chromatography (MAC). Using this protocol, it is possible to obtain highly purified microgram-milligram quantities of the TpsA protein of interest within 2-3 days.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19707189     DOI: 10.1038/nprot.2009.87

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  28 in total

1.  Identification of a locus involved in systemic dissemination of Yersinia enterocolitica.

Authors:  K M Nelson; G M Young; V L Miller
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  The crystal structure of filamentous hemagglutinin secretion domain and its implications for the two-partner secretion pathway.

Authors:  Bernard Clantin; Hélène Hodak; Eve Willery; Camille Locht; Françoise Jacob-Dubuisson; Vincent Villeret
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

3.  Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin.

Authors:  F D Menozzi; C Gantiez; C Locht
Journal:  FEMS Microbiol Lett       Date:  1991-02       Impact factor: 2.742

4.  Secretion of the Haemophilus influenzae HMW1 and HMW2 adhesins involves a periplasmic intermediate and requires the HMWB and HMWC proteins.

Authors:  J W St Geme; S Grass
Journal:  Mol Microbiol       Date:  1998-02       Impact factor: 3.501

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Novel vectors for co-expression of two proteins in E. coli.

Authors:  N Kholod; T Mustelin
Journal:  Biotechniques       Date:  2001-08       Impact factor: 1.993

7.  Efficacy of an acellular pertussis vaccine among adolescents and adults.

Authors:  Joel I Ward; James D Cherry; Swei-Ju Chang; Susan Partridge; Hang Lee; John Treanor; David P Greenberg; Wendy Keitel; Stephen Barenkamp; David I Bernstein; Robert Edelman; Kathryn Edwards
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

8.  The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis.

Authors:  Susan Grass; Amy Z Buscher; W Edward Swords; Michael A Apicella; Stephen J Barenkamp; Neil Ozchlewski; Joseph W St Geme
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

9.  Crystallization of truncated hemolysin A from Proteus mirabilis.

Authors:  Luke Bailey; Sean Agger; Luke Peterson; James Thompson; Todd Weaver
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-04-01

Review 10.  Protein glycosylation in bacterial mucosal pathogens.

Authors:  Christine M Szymanski; Brendan W Wren
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

View more
  12 in total

1.  Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.

Authors:  Koushik Roy; Scott Bartels; Firdausi Qadri; James M Fleckenstein
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery.

Authors:  Pardeep Kumar; F Matthew Kuhlmann; Kirandeep Bhullar; Hyungjun Yang; Bruce A Vallance; Lijun Xia; Qingwei Luo; James M Fleckenstein
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

3.  Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development.

Authors:  Subhra Chakraborty; Arlo Randall; Tim J Vickers; Doug Molina; Clayton D Harro; Barbara DeNearing; Jessica Brubaker; David A Sack; A Louis Bourgeois; Philip L Felgner; Xiaowu Liang; Sachin Mani; Heather Wenzel; R Reid Townsend; Petra E Gilmore; Michael J Darsley; David A Rasko; James M Fleckenstein
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

4.  Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli.

Authors:  Koushik Roy; David J Hamilton; George P Munson; James M Fleckenstein
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

5.  Enterotoxigenic Escherichia coli Degrades the Host MUC2 Mucin Barrier To Facilitate Critical Pathogen-Enterocyte Interactions in Human Small Intestine.

Authors:  Alaullah Sheikh; Tamding Wangdi; Tim J Vickers; Bailey Aaron; Margot Palmer; Mark J Miller; Seonyoung Kim; Cassandra Herring; Rita Simoes; Jennifer A Crainic; Jeffrey C Gildersleeve; Sjoerd van der Post; Gunnar C Hansson; James M Fleckenstein
Journal:  Infect Immun       Date:  2021-11-22       Impact factor: 3.609

6.  Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Authors:  Pardeep Kumar; F Matthew Kuhlmann; Subhra Chakraborty; A Louis Bourgeois; Jennifer Foulke-Abel; Brunda Tumala; Tim J Vickers; David A Sack; Barbara DeNearing; Clayton D Harro; W Shea Wright; Jeffrey C Gildersleeve; Matthew A Ciorba; Srikanth Santhanam; Chad K Porter; Ramiro L Gutierrez; Michael G Prouty; Mark S Riddle; Alexander Polino; Alaullah Sheikh; Mark Donowitz; James M Fleckenstein
Journal:  J Clin Invest       Date:  2018-06-25       Impact factor: 14.808

7.  Adhesin degradation accelerates delivery of heat-labile toxin by enterotoxigenic Escherichia coli.

Authors:  Koushik Roy; Rita Kansal; Scott R Bartels; David J Hamilton; Salwa Shaaban; James M Fleckenstein
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

8.  Conservation and immunogenicity of novel antigens in diverse isolates of enterotoxigenic Escherichia coli.

Authors:  Qingwei Luo; Firdausi Qadri; Rita Kansal; David A Rasko; Alaullah Sheikh; James M Fleckenstein
Journal:  PLoS Negl Trop Dis       Date:  2015-01-28

9.  Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli.

Authors:  Koushik Roy; David J Hamilton; James M Fleckenstein
Journal:  Clin Vaccine Immunol       Date:  2012-08-08

10.  Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.

Authors:  Qingwei Luo; Tim J Vickers; James M Fleckenstein
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.